Mavis Nye BCaH
Mavis Nye Foundation
It really began in the 1950`s when aged 15 she met Ray who was to become her lifelong partner.
He was an apprentice in the Royal Naval Dockyard in Chatham. They would meet during lunch breaks and later in the day. He would have on his clothes the fine invisible dust of asbestos. No one at that time warned them that this would in later life become a major issue. After their first year together Ray was called up for National Service. The 2 years separation was no barrier to asbestos contamination because unwittingly she was already exposed.
On Rays demob they got married and he returned to his trade in the shipyard. Together over the years that followed they raised a family and lived a
normal life together.
It was 49 years later that the devastating consequences’ of their first meeting would now return. In 2009 Mavis was suddenly aware that her breathing was laboured and this quickly resulted during a short walk to the shop across the road that she was now unable to breath. An urgent appointment with our GP was made and within hours she was admitted into Hospital. & 7 ltrs of Fluid were drained from her lung.
After weeks of tests and Biopsies, she was given the news that she had mesothelioma. It was explained that it was a Terminal Cancer. That there was no cure and no treatment available. The prognosis was a life expectancy of about 3 months, and that she was advised to return home and put her affairs in order.
A patients Story of Asbestos and mesothelioma
EVEN MORE SEMINARS
Mohamed Torky Hospital Germans Trias i pujol. Barcelona. Spain
Role of Radial-EBUS in diagnosis of lung cancer.
Prof Adam Waldman MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging
Biomarkers in Adult Glioma
Emlyn Samuel Cancer Research UK
Brexit: getting the best outcome for research and patients
Mylaine Riobe MD, FABOIM, FACOG Riobe Institute of Integrative Medicine
Cancer is not random! Evolving mechanisms for cancer causation and prevention
Dr Anita Rose The Raphael Hospital
Cognitive Issues in Multiple Sclerosis